Inici › Leucèmia › Carolina del Nord › Durham
Assaigs clínics de Leucèmia a Durham, NC
13 estudis de Leucèmia busquen participants en centres de Durham i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
ReclutantFase 3
- Quetzal Site 27, Chapel Hill · a 10 mi
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
ReclutantFase 1/2
- Duke University Medical Center, Durham
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
ReclutantFase 3
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · a 10 mi
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
Reclutant
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · a 10 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutantFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · a 10 mi
Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)
ReclutantVoluntaris sans benvinguts
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi
Registry of Older Patients With Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
A Study of Revumenib and Mezigdomide in People With Leukemia
ReclutantFase 1/2
- University of North Carolina (Data Collection Only), Chapel Hill · a 10 mi
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
ReclutantFase 2/3
- Duke University, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutantFase 1
- Duke Blood Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
ReclutantEstudi observacional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ReclutantFase 2
- Durham VA Medical Center, Durham, NC, Durham
Assaigs de Leucèmia en altres ciutats
- Houston, TX28 estudis
- Boston, MA25 estudis
- New York City, NY19 estudis
- Los Angeles, CA16 estudis
- Chicago, IL16 estudis
- Baldwin Park, CA12 estudis
- Columbus, OH12 estudis
- Nashville, TN12 estudis
- Philadelphia, PA12 estudis
- Milwaukee, WI11 estudis
- Atlanta, GA11 estudis
- Seattle, WA11 estudis
Altres estudis a Durham
- Càncer de mama63 estudis
- Càncer (tots els tipus)58 estudis
- Càncer de pulmó de cèl·lules no petites39 estudis
- Mieloma múltiple37 estudis
- Càncer metastàtic33 estudis
- Leucèmia mieloide aguda33 estudis
- Càncer de pulmó32 estudis
- Càncer de pròstata32 estudis
- Càncer colorrectal28 estudis
- Leucèmia limfàtica crònica27 estudis
- Càncer d'ovari27 estudis
- Insuficiència cardíaca26 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.